10-69180452-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000359655.9(SUPV3L1):āc.161G>Cā(p.Gly54Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000359655.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUPV3L1 | NM_003171.5 | c.161G>C | p.Gly54Ala | missense_variant | 1/15 | ENST00000359655.9 | NP_003162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUPV3L1 | ENST00000359655.9 | c.161G>C | p.Gly54Ala | missense_variant | 1/15 | 1 | NM_003171.5 | ENSP00000352678 | P1 | |
SUPV3L1 | ENST00000471069.5 | n.203G>C | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
SUPV3L1 | ENST00000422378.1 | c.161G>C | p.Gly54Ala | missense_variant | 1/6 | 5 | ENSP00000409072 | |||
SUPV3L1 | ENST00000483572.5 | n.172G>C | non_coding_transcript_exon_variant | 1/8 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.161G>C (p.G54A) alteration is located in exon 1 (coding exon 1) of the SUPV3L1 gene. This alteration results from a G to C substitution at nucleotide position 161, causing the glycine (G) at amino acid position 54 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.